Michael Ashby

2.1k total citations
53 papers, 1.4k citations indexed

About

Michael Ashby is a scholar working on Public Health, Environmental and Occupational Health, Anesthesiology and Pain Medicine and Surgery. According to data from OpenAlex, Michael Ashby has authored 53 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Public Health, Environmental and Occupational Health, 9 papers in Anesthesiology and Pain Medicine and 8 papers in Surgery. Recurrent topics in Michael Ashby's work include Palliative Care and End-of-Life Issues (16 papers), Pain Management and Opioid Use (9 papers) and Grief, Bereavement, and Mental Health (8 papers). Michael Ashby is often cited by papers focused on Palliative Care and End-of-Life Issues (16 papers), Pain Management and Opioid Use (9 papers) and Grief, Bereavement, and Mental Health (8 papers). Michael Ashby collaborates with scholars based in Australia, United Kingdom and New Zealand. Michael Ashby's co-authors include Melanie Wakefield, Jill Ainslie, R.M.G. Wells, Justin A. MacDonald, David Brumley, Brian Kelly, Penelope Schofield, Peter Hudson, Sanchia Aranda and Linda J. Kristjanson and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Michael Ashby

52 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Ashby Australia 21 466 281 226 204 201 53 1.4k
Derrick J. Pounder United Kingdom 31 283 0.6× 84 0.3× 152 0.7× 49 0.2× 422 2.1× 118 2.9k
Douglas A. Conner United States 16 585 1.3× 32 0.1× 405 1.8× 329 1.6× 106 0.5× 31 1.9k
Orla Smith Canada 23 348 0.7× 158 0.6× 135 0.6× 292 1.4× 211 1.0× 102 1.7k
Kris M. Jamsen Australia 22 162 0.3× 163 0.6× 248 1.1× 54 0.3× 40 0.2× 40 1.6k
Colleen M. Renier United States 21 450 1.0× 36 0.1× 89 0.4× 197 1.0× 80 0.4× 79 1.7k
Elizabeth Juarez‐Colunga United States 24 217 0.5× 26 0.1× 206 0.9× 248 1.2× 177 0.9× 72 1.8k
Brian J. Anderson United States 21 60 0.1× 100 0.4× 203 0.9× 89 0.4× 110 0.5× 54 1.6k
Annina Seiler Switzerland 16 223 0.5× 42 0.1× 213 0.9× 121 0.6× 245 1.2× 46 1.0k
Christina Stanley United States 20 381 0.8× 44 0.2× 234 1.0× 64 0.3× 64 0.3× 57 2.2k
Vibeke Brix Christensen Denmark 24 126 0.3× 129 0.5× 181 0.8× 158 0.8× 33 0.2× 92 1.9k

Countries citing papers authored by Michael Ashby

Since Specialization
Citations

This map shows the geographic impact of Michael Ashby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Ashby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Ashby more than expected).

Fields of papers citing papers by Michael Ashby

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Ashby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Ashby. The network helps show where Michael Ashby may publish in the future.

Co-authorship network of co-authors of Michael Ashby

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Ashby. A scholar is included among the top collaborators of Michael Ashby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Ashby. Michael Ashby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chua, Chong Chyn, Sun Loo, Chun Yew Fong, et al.. (2025). Final analysis of the phase 1b Chemotherapy and Venetoclax in Elderly Acute Myeloid Leukemia Trial (CAVEAT). Blood Advances. 9(8). 1827–1835. 4 indexed citations
2.
Tiong, Ing Soo, Devendra Hiwase, Ashish Bajel, et al.. (2024). Targeting Molecular Measurable Residual Disease and Low-Blast Relapse in AML With Venetoclax and Low-Dose Cytarabine: A Prospective Phase II Study (VALDAC). Journal of Clinical Oncology. 42(18). 2161–2173. 18 indexed citations
3.
Stirling, Christine, Fran McInerney, Sharon Andrews, et al.. (2013). A tool to aid talking about dementia and dying – Development and evaluation. Collegian Journal of the Royal College of Nursing Australia. 21(4). 337–343. 15 indexed citations
4.
Robinson, AL, et al.. (2010). Dementia knowledge of RACF staff and family carers. Australasian Journal on Ageing. 29. 36. 1 indexed citations
5.
Jackson, Kate, Michael Ashby, David Brumley, et al.. (2010). The Effectiveness and Adverse Effects profile of “Burst” Ketamine in Refractory Cancer Pain: The Vcog Pm 1-00 Study. Journal of Palliative Care. 26(3). 176–183. 39 indexed citations
6.
Goodchild, Colin S., et al.. (2008). Combination Therapy with Flupirtine and Opioid: Open-Label Case Series in the Treatment of Neuropathic Pain Associated with Cancer. Pain Medicine. 9(7). 939–949. 20 indexed citations
8.
Mendelson, Danuta & Michael Ashby. (2004). The medical provision of hydration and nutrition: two very different outcomes in Victoria and Florida.. PubMed. 11(3). 282–91. 6 indexed citations
9.
Seed, Alison, Rhoda E. Kuc, Anthony P. Davenport, et al.. (2003). First demonstration in humans of systemic neutral endopeptidase and endothelin converting enzyme inhibition using a new orally active dual metalloprotease inhibitor SLV 306. Journal of the American College of Cardiology. 41(6). 265–265. 1 indexed citations
10.
Ashby, Michael & Kate Jackson. (2003). Opioids in palliative care: emerging clinical trends. Internal Medicine Journal. 33(7). 265–266. 5 indexed citations
11.
Jackson, Kate, et al.. (2001). “Burst” Ketamine for Refractory Cancer Pain. Journal of Pain and Symptom Management. 22(4). 834–842. 78 indexed citations
12.
McGuckin, Michael A., et al.. (2001). Evaluation of a patient-empowering hand hygiene programme in the UK. Journal of Hospital Infection. 48(3). 222–227. 114 indexed citations
13.
Ashby, Michael, et al.. (1997). Plasma morphine and glucuronide (M3G and M6G) concentrations in hospice inpatients. Journal of Pain and Symptom Management. 14(3). 157–167. 75 indexed citations
14.
Ashby, Michael, Melanie Wakefield, & John Beilby. (1995). General practitioners' knowledge and use ofliving wills. BMJ. 310(6974). 230.1–230.1. 15 indexed citations
15.
Coleman, A, et al.. (1995). Subcutaneous fentanyl and sufentanil infusion substitution for morphine intolerance in cancer pain management. Pain. 63(2). 263–269. 98 indexed citations
16.
Ashby, Michael, et al.. (1991). Therapeutic ratio and defined phases: proposal of ethical framework for palliative care.. BMJ. 302(6788). 1322–1324. 26 indexed citations
17.
Belli, Laura, Suzy Scholl, Alain Livartowski, et al.. (1989). Resection of pulmonary metastases in osteosarcoma. A retrospective analysis of 44 patients. Cancer. 63(12). 2546–2550. 51 indexed citations
18.
Ashby, Michael, et al.. (1988). The role of radiotherapy in the management of primary cutaneous neuroendocrine tumors (merkel cell or trabecular carcinoma): Experience at the peter maccallum cancer institute (Melbourne, Australia). International Journal of Radiation Oncology*Biology*Physics. 14(6). 1077–1084. 103 indexed citations
19.
Singh, Pritam, et al.. (1983). A semi‐automatic volumetric filling machine for dispensing insect diets. New Zealand Journal of Zoology. 10(4). 413–417. 5 indexed citations
20.
Ashby, Michael, et al.. (1963). Recurrent Transient Monocular Blindness. BMJ. 2(5362). 892.1–897. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026